|
Company Report
|
Pharmaceutical Company Outlook to 2014
PharmaVitae universe Rx sales are forecast to expand at a 2008-14 CAGR of 1.2%, down 9.3 percentage points from 2002-08. The underlying cause of this falling rate is the much-discussed genericization of small molecule products. However, not all sectors are equally exposed, prompting a shake-up of the industry and an increasing pursuit of cost savings to sustain operating profit growth rates.
|
|
Read more...
|
|
|
Market Report
|
Benchmarking the Pharmaceutical Market by Drug Delivery to 2014
Drug delivery can play an important role at all stages of a drug's lifecycle and has become an ever present feature in the business model of the leading pharmaceutical companies. Using the PharmaVitae Explorer database, the report provides an in depth sales analysis of the specific routes of administration driving the pharmaceutical market out to 2014.
|
|
Read more...
|
|
|
Company Report
|
Pharmaceutical Licensing Overview - Risk-aversion breeds creativity as externalization intensifies
Big Pharma continues to restructure its internal R&D departments as part of widespread cost-cutting measures to help reduce the impact of the impending 2011 patent cliff. To fill pipeline voids with new products, companies continue to make acquisitions and form partnerships with small pharma, biotech companies and academia, although the relationships between each are becoming increasingly dynamic.
|
|
Read more...
|
|
|
Market Report
|
Pharmaceutical Key Trends 2010 - The patent cliff dominates but growth opportunities remain
Pharma faces a number of key resistors to growth including the impending 2011 patent cliff which is set to erode $78 billion in global branded sales from drugs facing patent expiry over the 2010/14 period (plus $32 billion from continued erosion of already expired brands). Price cuts, reimbursement restrictions and growing regulatory pressure are further set to limit sales growth going forward.
|
|
Read more...
|
|
|
Market Report
|
U.S. Preterm Infant Care Market
Preterm infant care forms a significant part of the pediatric healthcare market in the U.S. as preterm births are one of the leading causes of infant mortality in the country. One in every eight births in the U.S. are preterm, and the condition is on an alarming rise due to factors such as induced fertility, labor treatments, poor prenatal care, inappropriate maternal age, obesity, and smoking.
|
|
Read more...
|
|
|
Market Report
|
Disease Modification in Rheumatoid Arthritis - Anti-TNFs defend first-line biologic position despite competition
Datamonitor forecasts that total sales for the seven major rheumatoid arthritis markets will grow from $7 billion in 2007 to over $12 billion in 2017. The sustained uptake of anti-TNFs combined with the launch of several new biologic products will drive growth in the short-and mid-term. However, biosimilar entry will cause a small contraction in market value at the end of the forecast period.
|
|
Read more...
|
|
|
Market Report
|
Disease Modification in Rheumatoid Arthritis - New drug targets compete in crowded market
Drugs with new mechanisms, in particular Pfizer's oral JAK inhibitor CP-690,550 and Chugai/Roche's Actemra (tocilizumab), will launch for rheumatoid arthritis and should offer advantages over current therapies, but do not come without some safety signals. Late-stage pipeline launches will be a major contributor to market growth from $7.4 billion in 2008 to $11.5 billion in 2018.
|
|
Read more...
|
|
|
Market Report
|
Pain Market Overview - Non-traditional analgesics and opioid reformulations to sustain sector growth
The mature pain market has experienced a turbulent 4-year period during which the estimated seven major market sales value has fallen from an all-time high in 2004 down to $24.29 billion in 2007. However, through the growing use of non-traditional analgesics and the emergence of a number of opioid reformulations, the market is set to consolidate in a new phase of growth and prosperity.
|
|
Read more...
|
|
|
Market Report
|
The Pain Management Market Outlook To 2014: Competitive landscape, pipeline analysis and growth opportunities
This report provides comprehensive coverage of major markets within the global pain management area, incorporating a epidemiological analysis of key neuropathic and nociceptive pain indications and the main factors impacting their prevalence. This report reviews the factors and underlying trends that are shaping the pain management market and identifies areas of potential growth.
|
|
Read more...
|
|
|
Market Report
|
Neuropathic Pain - Brighter future for pipeline drugs while current brands downgraded
Datamonitor forecasts the neuropathic pain market to more than double in value from 2008 to total $5.2 billion by 2018 across the seven major markets (US, Japan, and the 5EU [France, Germany, Italy, Spain and the UK]). Although the US will provide the greatest increase in value over this period, Japan and the 5EU markets will post double-digit compound annual growth rates.
|
|
Read more...
|
|
|
Market Report
|
Stakeholder Insight: Osteoarthritis - Drug development lags behind rising osteoarthritis population
Datamonitor expect osteoarthritis prevalence to grow by over 10 million by 2020, owing mainly to an aging population. In the near-term the approach to treatment will remain constant, with improved side-effects dominating the unmet needs. However, therapies which target the underlying causes of osteoarthritis have the potential to reshape osteoarthritis treatment.
|
|
Read more...
|
|
|
Market Report
|
Stakeholder Opinions: Back Pain - Gain competitive edge by targeting subpopulations
Back pain can restrict activity and quality of everyday life and in some cases is a potentially chronic and even crippling condition. Therefore, back pain exerts a large economic impact on society. Due to the high prevalence of back pain, Datamonitor believes that the condition represents a commercially attractive target to pharmaceutical companies with an interest in the pain market.
|
|
Read more...
|
|
|
Market Report
|
Medical Imaging - Global Displays and Post-Processing Software Market (2009 -2014)
Rising healthcare costs and the increasing demand for healthcare services have effected a significant transformation in the field of healthcare image management software over the last decade. Healthcare equipment vendors are now seeking to provide an integrated diagnostic model facilitating patient-centric, evidence-based healthcare. The major features of post-processing include workflow tasks such as image processing, image reconstruction, computer-aided detection, three-dimensional (3D) view generation, and quality control.
|
|
Read more...
|
|
|
Market Report
|
US and European Ultrasound Systems Market: Increasing Demand to Drive Growth
GlobalData, the industry analysis specialists' new report, "US and European Ultrasound Systems Market: Increasing Demand to Drive Growth", finds that an aging population growth coupled with cost-effectiveness and advancements in technology are expected to drive growth in the US and Europe ultrasound systems market. The report highlights these factors as the key drivers for the US and Europe ultrasound systems market.
|
|
Read more...
|
|
|
Market Report
|
Global Hip And Knee Implants Market: Market Penetration to Drive Growth
GlobalData, the industry analysis specialists' new report, "Global Hip and Knee Implants: Market Penetration to Drive Growth" finds that an increasing incidence of osteoarthritis in the aging population pool will drive growth of hip and knee implants market, globally. An increasing aging population and innovative product offerings are expected to drive revenue growth and investor interests in the global hip and knee implants markets.
|
|
Read more...
|
|
|
Market Report
|
Europe Remote Patient Monitoring Market: Strategic Analysis and Opportunity Assessment
GlobalData's "Europe Remote Patient Monitoring Market: Strategic Analysis and Opportunity Assessment" report is an essential source of data and analysis on the Europe remote patient monitoring market with complete coverage on the market landscape. The report identifies the key trends shaping and driving the dynamism in the Europe remote patient monitoring market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also provides valuable insight on the pipeline products within the Europe remote patient monitoring market.
|
|
Read more...
|
|
|
|
|
|
|
Market Report
|
Europe Orthopedic Biomaterials: Product Penetration to Drive Growth
GlobalData's "Europe Orthopedic Biomaterials Market: Market Assessment, Insight and Forecasts to 2015" report is an essential source of data and analysis on the Europe orthopedic biomaterials market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on four market categories - bone allografts, bone graft substitutes, bone growth stimulators, DBM and viscosupplementation. The report identifies the key trends shaping and driving the dynamism in the Europe orthopedic biomaterials market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also analyses the M&A landscape with special focus on the market participants that have been the most M&A active. The report also provides valuable insight on the pipeline products within the Europe orthopedic biomaterials market.
|
|
Read more...
|
|
|
Market Report
|
Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015
GlobalData's "Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015" report is an essential source of information and analysis on the global cardiac assist devices market. The report identifies the key trends shaping and driving the dynamism in the global cardiac assist devices market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global cardiac assist devices sector.
|
|
Read more...
|
|
Farmavita.Net Journal 
